Vittoria Esposito

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15

Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15

Xiang Gao, Lianghu Huang, Fabrizio Grosjean et al. · Kidney International · 2011 · 67 citations

Ketoacids Reduces, Urology, Renal Disease +10

CHOP deficiency results in elevated lipopolysaccharide-induced inflammation and kidney injury

Vittoria Esposito, Fabrizio Grosjean, Liang‐Fu Huang et al. · American Journal of Physiology-Renal Physiology · 2012 · 65 citations · Full text

Chop Deficiency Results, Immunology, Renal Inflammation +24